CARLEVENT levodopa/carbidopa/entacapone 200/50/200 mg tablet bottle Australia - inglese - Department of Health (Therapeutic Goods Administration)

carlevent levodopa/carbidopa/entacapone 200/50/200 mg tablet bottle

medis pharma pty ltd - levodopa, quantity: 200 mg; carbidopa monohydrate, quantity: 54 mg (equivalent: carbidopa, qty 50 mg); entacapone, quantity: 200 mg - tablet, film coated - excipient ingredients: powdered cellulose; microcrystalline cellulose; sodium sulfate; carmellose sodium; magnesium stearate; hyprolose; trehalose dihydrate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin - levodopa/carbidopa/entacapone is indicated for the management of patients with parkinson?s disease who are experiencing motor fluctuations.

DUODOPA Israele - inglese - Ministry of Health

duodopa

abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - gel - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa - levodopa - treatment of advanced levodopa-responsive parkinson's disease with severe motor fluctuations and hyper-/dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results.

Carbidopa/Levodopa Fair-Med 10 mg/100 mg Tablets Irlanda - inglese - HPRA (Health Products Regulatory Authority)

carbidopa/levodopa fair-med 10 mg/100 mg tablets

fairmed healthcare gmbh - carbidopa; levodopa - tablet - 10/100 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Carbidopa/Levodopa Fair-Med 25 mg/100 mg Tablets Irlanda - inglese - HPRA (Health Products Regulatory Authority)

carbidopa/levodopa fair-med 25 mg/100 mg tablets

fairmed healthcare gmbh - carbidopa; levodopa - tablet - 25/100 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Carbidopa/Levodopa Fair-Med 25 mg/250 mg Tablets Irlanda - inglese - HPRA (Health Products Regulatory Authority)

carbidopa/levodopa fair-med 25 mg/250 mg tablets

fairmed healthcare gmbh - carbidopa; levodopa - tablet - 25/250 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Carbidopa/Levodopa Fair-Med Tablets 12.5mg/50mg Malta - inglese - Malta Medicines Authority

carbidopa/levodopa fair-med tablets 12.5mg/50mg

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - carbidopa, levodopa - tablet - carbidopa 13.5 mg levodopa 50 mg - anti-parkinson drugs

Carbidopa/Levodopa Fair-Med Tablets 10mg/100mg Malta - inglese - Malta Medicines Authority

carbidopa/levodopa fair-med tablets 10mg/100mg

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - carbidopa, levodopa - tablet - carbidopa 10.8 mg levodopa 100 mg - anti-parkinson drugs

Carbidopa/Levodopa Fair-Med Tablets 25mg/100mg Malta - inglese - Malta Medicines Authority

carbidopa/levodopa fair-med tablets 25mg/100mg

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - carbidopa, levodopa - tablet - carbidopa 27 mg levodopa 100 mg - anti-parkinson drugs

STALEVO 125/31.25/200 levodopa/carbidopa (as monohydrate)/entacapone  tablet bottle Australia - inglese - Department of Health (Therapeutic Goods Administration)

stalevo 125/31.25/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle

sandoz pty ltd - levodopa, quantity: 125 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 33.8 mg (equivalent: carbidopa, qty 31.25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.

STALEVO 75/18.75/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle Australia - inglese - Department of Health (Therapeutic Goods Administration)

stalevo 75/18.75/200 levodopa/carbidopa (as monohydrate)/entacapone tablet bottle

sandoz pty ltd - levodopa, quantity: 75 mg; entacapone, quantity: 200 mg; carbidopa monohydrate, quantity: 20.25 mg (equivalent: carbidopa, qty 18.75 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; maize starch; mannitol; povidone; glycerol; hypromellose; polysorbate 80; iron oxide red; sucrose; titanium dioxide - stalevo is indicated for the management of patients with parkinson's disease who are experiencing motor fluctuations.